Absorption of Insulin Following Subcutaneous Bolus Administration With Different Bolus Durations

NCT01792323 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Insulin LISPRO

Sponsor

Medical University of Graz

Collaborators

[object Object]